Login to Your Account

Valeant's Pipeline Star Potiga Gets FDA Approval for Seizures

By Trista Morrison

Tuesday, June 14, 2011
Six months after receiving a complete response letter for epilepsy drug Potiga (ezogabine), Valeant Pharmaceuticals International Inc. and partner GlaxoSmithKline plc gained approval of the potassium channel opener as an adjunctive treatment for partial-onset seizures.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription